摩根大通增持信达生物58.59万股 每股作价约79.23港元

Core Viewpoint - Morgan Stanley increased its stake in Innovent Biologics (01801) by purchasing 585,900 shares at a price of HKD 79.232 per share, totaling approximately HKD 46.422 million, raising its ownership to about 87.2176 million shares, which represents a 5.02% stake [1] Group 1 - Morgan Stanley's recent purchase of shares indicates a positive outlook on Innovent Biologics' future performance [1] - The total investment made by Morgan Stanley in this transaction is approximately HKD 46.422 million [1] - Following the acquisition, Morgan Stanley's total shareholding in Innovent Biologics is now approximately 87.2176 million shares [1]